COMMUNIQUÉS West-GlobeNewswire

ORYZON Presents New Positive REIMAGINE Efficacy Data of Vafidemstat in the Treatment of Aggression

03/10/2019 - 14:00

Vafidemstat reduced aggression and improved function across the three investigated psychiatric disorders, ADHD, ASD and BPD REIMAGINE data supports vafidemstat as an emerging therapeutic option in the treatment of [...]

AgraFlora Organics se prépare pour les nouvelles réglementations de Santé Canada du 17 octobre avec son usine de produits comestibles verticalement intégrée en vue de commercialiser des produits à forte teneur en CBD sur réception de sa licence de R & D

03/10/2019 - 14:03

VANCOUVER, Colombie-Britannique, 03 oct. 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) une société internationale de [...]

REPEAT - AgraFlora Organics Prepares for October 17th Health Canada Regulations with Vertically Integrated Edibles Infrastructure, To Commercialize High-CBD Varietals Under R&D License

03/10/2019 - 14:03

VANCOUVER, British Columbia, Oct. 03, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]

De nouvelles données de 48 semaines démontrent que Trogarzo(MD) demeure efficace et sécuritaire

03/10/2019 - 14:17

MONTRÉAL, 03 oct. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que de nouvelles données de 48 semaines issues de l’étude étendue TMB-311 confirme que Trogarzo MD [...]

New 48-Week Data Presented at IDWeek Show Trogarzo® Remains Safe and Effective

03/10/2019 - 14:17

MONTREAL, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that new 48-week data from the TMB-311 extension study confirm that Trogarzo ® provides durable [...]

Parexel Appoints John Bell Executive Vice President and Chief Quality Officer

03/10/2019 - 14:30

Clinical research veteran to lead Quality initiatives across global Organization in support of enhanced patient focus; appointed to company’s Executive Leadership Team DURHAM, N.C. and BOSTON, Oct. 03, 2019 (GLOBE [...]

Corvus Pharmaceuticals to Present Updated Data from CPI-006 Clinical Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

03/10/2019 - 14:30

CPI-006 data to be presented in oral presentation and poster presentation BURLINGAME, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company [...]

Alimera Obtains Marketing Authorization for ILUVIEN® in Portugal for the Treatment of Non-Infectious Posterior Uveitis

03/10/2019 - 14:30

Company continues strategy to grow the use of ILUVIEN internationally through geographic expansion and further penetration into existing markets ATLANTA, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq [...]

Tetra Bio-Pharma Provides Regulatory Update for Its CAUMZ(TM) Kit

03/10/2019 - 14:30

U.S. Food and Drug Administration (FDA) allows evaluation of CAUMZ Kit as a combination drug/device product, providing clarity on regulatory approval pathway This is a first step in the regulatory strategy to bring [...]

American Cannabis Company, Inc. Strengthens Team By Adding New VP of Sales & Marketing

03/10/2019 - 14:30

DENVER, CO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business cannabis and hemp consulting solutions provider, is pleased to [...]

PDS Biotechnology Corp. Announces Clinical Collaboration with Merck

03/10/2019 - 14:30

PDS0101- KEYTRUDA® (pembrolizumab) Combination to be Evaluated in First Line Treatment of Metastatic Head and Neck Cancer BERKELEY HEIGHTS, N.J., Oct. 03, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS [...]

Marrone Bio Innovations to Attend the MicroCap Rodeo Investment Conference in Austin

03/10/2019 - 14:31

DAVIS, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced that management has been [...]

Golden Leaf Holdings Ltd. Announces Termination of Employment of President of Medical Marijuana Group Consulting Ltd. and Medical Marihuana Group Corporation

03/10/2019 - 14:45

TORONTO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” of the “Company”), a pioneering cannabis company with cultivation, production and retail operations built [...]

Obalon Announces Repayment of All Long-Term Debt and Regaining of Compliance with NASDAQ Listing Requirement

03/10/2019 - 15:00

SAN DIEGO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a San Diego-based company focused on commercializing the Obalon Balloon System, the first and only FDA-approved swallowable, gas- [...]

Thesecondopinion Celebrates 50 Years of Empowering the Cancer Community

03/10/2019 - 15:00

More than 10,000 patients have benefitted from a free second opinion about their disease and treatment options Of note during Breast Cancer Awareness Month: 35 percent were breast cancer patients SAN FRANCISCO, Oct. 03 [...]

Cerner and i2i Population Health Collaborate to Better Serve Medicaid Population

03/10/2019 - 15:00

Companies Aim to Improve Health Outcomes and Lower Costs for Underserved Communities KANSAS CITY, Mo., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN), a global health platform and innovation company [...]

Nemaura Medical Provides Update Regarding Commercial Launch of SugarBEAT® and First Patient User Experiences as Presented at EASD Symposia 2019 in Barcelona

03/10/2019 - 15:00

Loughborough, England, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and [...]

Autolus Announces Data Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

03/10/2019 - 15:08

Poster presentation will highlight preclinical data regarding feasibility, safety, and efficacy of AUTO6NG, a next generation programmed T cell product candidate for pediatric neuroblastoma LONDON, Oct. 03, 2019 (GLOBE [...]

Innovation Pharmaceuticals Clinical Trial of Oral Brilacidin in Ulcerative Colitis Program Expected to Commence in December; Top-Line Data in Q1 2020

03/10/2019 - 15:30

BEVERLY, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that management is finalizing [...]